Neurology NW Limited members' voluntary liquidation
Active Company no. 07356142 Incorporated Aug 2010 Professional Services SK postcode area
4 Anglesey Water, Poynton, Stockport, SK12 1LJ
The most recent insolvency notice for Neurology NW Limited is a Notices to creditors (MVL), published 16 October 2026 in The London Gazette. The office holder is Molly Monks, appointed 13 October 2026. Its last accounts filed at Companies House, to 31 August 2026, showed total assets of £1.5m and net assets of £1.4m. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Last filed balance sheet
As at 31 August 2026 · micro entity accounts · unaudited · filed 1 month before the first insolvency notice
Average employees during the period: 1
Insolvency notices (3)
-
Notices to creditors (MVL) 16 Oct 2026
The liquidator of NEUROLOGY NW LIMITED has set a deadline of 14 December 2026 for creditors to prove their claims.
-
Resolution for winding up (MVL) 16 Oct 2026
The company NEUROLOGY NW LIMITED resolved to voluntarily wind up and appointed Molly Monks as liquidator.
-
Appointment of liquidators (MVL) 16 Oct 2026
The notice announces that the members of Neuroology NW Limited have appointed Molly Monks as liquidator in a members’ voluntary liquidation.
What happens next
Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.
Owed money by Neurology NW Limited?
A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.
Related guidance
Frequently asked questions
Is Neurology NW Limited in financial difficulty?
No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for Neurology NW Limited (company no. 07356142) is a Notices to creditors (MVL), published 16 October 2026 in The London Gazette.
What were Neurology NW Limited's last filed accounts?
Neurology NW Limited's last accounts filed at Companies House, to 31 August 2026, showed total assets of £1.5m, net assets of £1.4m. For a distressed company the last filing often predates the insolvency by a year or more.
How many insolvency notices does Neurology NW Limited have?
Neurology NW Limited has 3 insolvency notices recorded in The London Gazette, the most recent being a Notices to creditors (MVL) on 16 October 2026.
What happens next?
Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.
Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.